Literature DB >> 6722735

Case-control study of ovarian cancer in Japan.

M Mori, H Kiyosawa, H Miyake.   

Abstract

A case-control study of 80 women with ovarian epithelial carcinoma and 160 individually age-matched controls were conducted to assess various factors associated with the incidence of ovarian cancer in Hokkaido, Japan. Among the characteristics studied, the following factors were significantly greater in the cases than in the controls: (1) blood group A; (2) never married or married late in life; (3) more frequent surgery for retroflexion of the uterus; (4) less use of contraceptive appliances; and (5) less daily use of cosmetics. It was inferred from these observations that ovarian cancer patients had a genetic predisposition and dysfunctional ovaries. Gonadal dysfunction among ovarian cancer patients presumably explained not only altered personality and behavior patterns, but also facilitated the pituitary gonadotropin activity which has been suggested as increasing the incidence of the disease experimentally.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6722735     DOI: 10.1002/1097-0142(19840615)53:12<2746::aid-cncr2820531235>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  ABO blood group and incidence of epithelial ovarian cancer.

Authors:  Margaret A Gates; Brian M Wolpin; Daniel W Cramer; Susan E Hankinson; Shelley S Tworoger
Journal:  Int J Cancer       Date:  2010-03-22       Impact factor: 7.396

2.  Ovarian cancer and ABO blood groups.

Authors:  J Henderson; V Seagroatt; M Goldacre
Journal:  J Epidemiol Community Health       Date:  1993-08       Impact factor: 3.710

3.  Irregular menses predicts ovarian cancer: Prospective evidence from the Child Health and Development Studies.

Authors:  Piera M Cirillo; Erica T Wang; Marcelle I Cedars; Lee-May Chen; Barbara A Cohn
Journal:  Int J Cancer       Date:  2016-04-29       Impact factor: 7.316

4.  Risk factors for ovarian cancer: a case-control study.

Authors:  M Booth; V Beral; P Smith
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

5.  The ABO Blood Group is an Independent Prognostic Factor in Patients with Ovarian Cancer.

Authors:  Qian Song; Jun-Zhou Wu; Sheng Wang; Zhong-Bo Chen
Journal:  J Cancer       Date:  2019-10-22       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.